According to the 2024 multi-society guidance from the ASA and other professional organizations, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies
Last year, the Trump administration struck a deal with Eli Lilly and Novo Nordisk to lower the prices of their popular obesity drugs in exchange for expanding access to those drugs in Medicare and Medicaid
Zhang YS, Zheng YD, Yuan Y, Chen SC, Xie BC
Many patients who struggle with obesity also suffer from high blood pressure, high cholesterol, sleep apnea, fatty liver, joint pain, back pain, pre-diabetes
For patients, it adds another layer of confidence when choosing an online or in-person medical weight loss provider
Coding Diabetes Medication - January 2, 2025 Do I Bill Medical or Dental